论文部分内容阅读
《Med Post》1984:20(7):32. Lozarus Boutis及其在希腊德阿让尼肿瘤研究所的工作助手报道,两种新的酶标记法可用来测定卵巢癌和睾丸癌在治疗后的疗效,并可预示肿瘤是否复发。Boutis在第二届国际人类肿瘤标记物会议上宣称,卵巢癌和睾丸癌病人血清中的唾液酸转移酶和核苷二磷酸酶为正常水平的4—10倍。他指出,45名卵巢癌病人和6名睾丸癌病人的血清唾液酸酶水平从450微微克分子量/小时/毫升增高至900微微克分子量/小时/毫升,而正常值大约为100微微克分子量/小时/毫升。
Med Post 1984:20(7):32. Lozarus Boutis and his aide at the Institute of Oncology in Dehajani, Greece reported that two new enzyme labeling methods can be used to measure ovarian cancer and testicular cancer after treatment. Efficacy, and can predict whether the tumor recurrence. Boutis declared at the 2nd International Conference on Human Tumor Markers that sialyltransferase and nucleoside diphosphatase in the serum of patients with ovarian and testicular cancer are 4 to 10 times normal. He pointed out that the serum sialidase level in 45 patients with ovarian cancer and 6 patients with testicular cancer increased from 450 pg/h/ml to 900 pg/h/ml, and the normal value was about 100 pg/h. Hours/ml.